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epidemics occur (e.g., diphtheria in eastern
Europe in the early and mid-1990s) (9). If
needed, the World Health Organization can
provide information on confirmed and uncon-
firmed epidemics on a weekly basis.
Travel and peacekeeping mission statistics
share similarities. In Namibia, the South African
Armed Forces had most often observed hepatitis
(unspecified), with rare cases of tuberculosis,
typhoid, and meningitis (unpub. SAMS report:
Disease Profile of South West Africa, 1989), as
did the UN mission to Namibia, where within 12
months and with 7,114 employees, seven cases of
hepatitis (mostly hepatitis A, some unspecified)
occurred (10). No other vaccine-preventable
infections were diagnosed in this UN mission.
Considering both risk (on the basis of
incidence rates) and impact of infection, the
priority for immunization (from highest to
lowest) is as follows: hepatitis A, hepatitis B,
rabies, poliomyelitis, yellow fever, typhoid fever,
influenza, diphtheria, tetanus, meningococcal
disease, Japanese encephalitis, cholera, and
measles. To administer all vaccines would be
extremely costly and may also result in an
increased rate of adverse side-effects. Immuniza-
tions against the more frequent, more severe
infections should be given priority.
If a mission is limited to one season,
environmental factors of that respective season
should be considered. This general rule is more
important for vector-borne than for vaccine-
preventable infections, except for influenza and
meningococcal disease.
Persons who are already immune (because of
previous immunization or immunity after
infection) need not be vaccinated. The latter
cause is particularly often true of hepatitis A;
troops recruited in developing countries have an
anti-hepatitis A virus seroprevalence rate close
to 100% (11). Hepatitis B immunization, except
for non- and low-responders, probably grants
lifelong protection (12); the same is likely for
measles vaccine.
Sometimes the host country may require
proof of some specific vaccination based on the
International Health Regulations (13), currently
under fundamental revision to become a more
effective tool in preventing the spread of
infections that may be a global hazard (14).
In addition to adequate epidemiologic
information and coordination between the
military, international health organizations, and
the host country, successful intervention efforts
require thorough knowledge of vaccine charac-
teristics with varying rates of efficacy and
duration of protection. Cost-benefit evaluations,
which would be very desirable, are unlikely in
areas of political instability.
Robert Steffen
Institute for Social and Preventive Medicine of the
University, Zurich, Switzerland
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Sexually Transmitted Diseases in Ukraine
To the Editor: With the political changes in
eastern Europe in the last 10 years have come
social and economic changes (1). Ukraine not487 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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only faces almost insurmountable problems as it
tries to form a new government, it also faces
many serious health issues including sexually
transmitted diseases (STDs).
Surveillance data from the Ukrainian STD
Center from January 1, 1989, through December
31, 1995, were analyzed on the basis of reports
received through 1997. In western Europe, the
incidence of syphilis and gonorrhea declined
from 1980 to 1991 to less than 2% per 100,000
persons for syphilis and less than  20% per
100,000 persons for gonorrhea. However, in
Ukraine, since 1989, the notification rate of
syphilis has skyrocketedfrom 5 per 100,000
persons in 1990 to 170 in 1995. In some regions,
this rate exceeds 220 cases per 100,000 persons.
Moreover, cases among children younger than
14 years of age are also increasing. In 1995, the
syphilis rate for persons older than 30 years of
age was 170 per 100,000; 600 per 100,000 girls
younger than 15 years of age; and 1,550 to 2,000
per 100,000 girls 15 to 16 years of age. The large
number of girls with the disease is in part due to
teenage prostitution (1).
Most syphilis and gonorrhea cases are
attributed to sexual transmission. Explanations
of this phenomenon include the rapid growth of
the sex industry, increasing numbers of
homeless persons and refugees in Ukrainian
cities, poor diagnostic facilities, punitive legisla-
tion that reduces the likelihood of going to
treatment services, and limited or inadequate
treatment (2).
The Ukrainian government is reviewing its
arrangements for the control of STDs, including
HIV/AIDS, to identify clear objectives and
priorities. Education and treatment would be
effective in preventing the spread of STDs in
Ukraine, but these measures are inadequately
funded (3). Evaluation and risk reduction are
also great weapons in preventing the spread of
STDs (4). However, the response of the local and
world communities has been inadequate in
stemming a major STD epidemic in Ukraine.
United Nations Childrens Fund (UNICEF)
is developing a long-term program in Ukraine
with a focus on STDs in adolescents and youth.
This comprehensive program will tackle not only
STDs but other related issues, such as HIV and
teenagers reproductive health (5).
Greater coordination of the agencies respon-
sible for STD control in Ukraine will be sought,
together with an expansion of health promotion
and prevention projects for young persons and
groups at high risk (6). An effective strategy for
the control of STDs in Ukraine will, therefore,
need to find ways to modify current programs
and the way they interact to create effective
control interventions.
Dmitry I. Ivanov
University of Alabama at Birmingham, Birmingham,
Alabama, USA
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Yellow Fever Vaccine
To the Editor: Monath et al. (1) outlined existing
facilities for distribution of yellow fever vaccines
in the United States and pointed to difficulties
for prospective vaccinees in remote locations.
Their recommendation that primary health-care
providers be allowed to dispense yellow fever
vaccination merits serious consideration. Accep-
tance of such a strategy in the United States
would inevitably be emulated elsewhere.
Nevertheless, before such a strategy is approved,
vaccine potency should be monitored at
distribution points, and a sample of vaccine
recipients should be examined for vaccine-
induced immune response.
In Nigeria, systematic investigation of
yellow fever vaccine distribution and transporta-
tion to remote locations has found loss in vaccine
potency. Vaccine in storage sites and immuniza-